116 related articles for article (PubMed ID: 15047216)
1. Premalignant lesions in the contralateral ovary of women with unilateral ovarian carcinoma.
Kaur TB; Shen T; Gaughan J; Thompson J; Houck KL; Richardson M; Hernandez E
Gynecol Oncol; 2004 Apr; 93(1):69-77. PubMed ID: 15047216
[TBL] [Abstract][Full Text] [Related]
2. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.
Piek JM; van Diest PJ; Zweemer RP; Jansen JW; Poort-Keesom RJ; Menko FH; Gille JJ; Jongsma AP; Pals G; Kenemans P; Verheijen RH
J Pathol; 2001 Nov; 195(4):451-6. PubMed ID: 11745677
[TBL] [Abstract][Full Text] [Related]
3. Histological features of the contralateral ovary in patients with unilateral ovarian cancer: a case control study.
Tresserra F; Grases PJ; Labastida R; Ubeda A
Gynecol Oncol; 1998 Dec; 71(3):437-41. PubMed ID: 9887246
[TBL] [Abstract][Full Text] [Related]
4. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology.
Kerner R; Sabo E; Gershoni-Baruch R; Beck D; Ben-Izhak O
Gynecol Oncol; 2005 Nov; 99(2):367-75. PubMed ID: 16051332
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
Seidman JD; Wang BG
Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
[TBL] [Abstract][Full Text] [Related]
11. [Expression of AIB1 protein in epithelial ovarian cancer cells and its impact on apoptosis].
Han XY; Chen Y; Hou MM; Zhang J; Yang KX; Chen YY; Qie MR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):619-22, 634. PubMed ID: 18798508
[TBL] [Abstract][Full Text] [Related]
12. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
13. Exploratory study of ovarian intraepithelial neoplasia.
Brewer MA; Ranger-Moore J; Baruche A; Alberts DS; Greene M; Thompson D; Liu Y; Davis J; Bartels PH
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):299-305. PubMed ID: 15734950
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle and apoptotic proteins in relation to ovarian epithelial morphology.
Nnene IO; Nieto JJ; Crow JC; Sundaresan M; MacLean AB; Perrett CW; Hardiman P
Gynecol Oncol; 2004 Jan; 92(1):247-51. PubMed ID: 14751166
[TBL] [Abstract][Full Text] [Related]
15. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
16. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
17. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability.
Okamura H; Katabuchi H
Ital J Anat Embryol; 2001; 106(2 Suppl 2):263-76. PubMed ID: 11732586
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of cell-cycle proteins in gastric precancerous lesions.
Anagnostopoulos GK; Stefanou D; Arkoumani E; Karagiannis J; Paraskeva K; Chalkley L; Habilomati E; Tsianos E; Agnantis NJ
J Gastroenterol Hepatol; 2008 Apr; 23(4):626-31. PubMed ID: 18397488
[TBL] [Abstract][Full Text] [Related]
19. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
[TBL] [Abstract][Full Text] [Related]
20. The association between polycystic ovaries and endometrial cancer.
Pillay OC; Te Fong LF; Crow JC; Benjamin E; Mould T; Atiomo W; Menon PA; Leonard AJ; Hardiman P
Hum Reprod; 2006 Apr; 21(4):924-9. PubMed ID: 16361289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
